van den Bosch, Sibbeliene E.
Hutten, Barbara A.
Ibrahim, Shirin
Wiegman, Albert
Pang, Jing
Watts, Gerald F.
Corpeleijn, Willemijn E.
Article History
Received: 5 April 2024
Revised: 6 May 2024
Accepted: 4 June 2024
First Online: 18 June 2024
Declarations
:
: SevdB: none. BAH: received a research grant from Silence Therapeutics paid to the institution. SI: none. AW: received research grants, consulting fees, or lecture fees from Algorithm, Amgen, Amryt, Esperion, Novartis, Sanofi-Regeneron, Silence Therapeutics, and Ultragenyx. JP: none. GFW: received research grants, consulting fees, or lecture fees from Amgen, Arrowhead, Esperion, Novartis, Silence Therapeutics, Novo Nordisk, and CSL Sequirus. WEC: none.